Grifols (GRFS) Research & Development (2011 - 2018)

Grifols (GRFS) reported Research & Development of $69.6 million for Q2 2018, up 1.37% on a YoY basis from $68.6 million in Q2 2017, and up 1.37% quarter-over-quarter from $68.6 million in Q2 2017.

Grifols (GRFS) Research & Development (2011 - 2018) Analysis & Trends

Grifols has reported Research & Development for 7 years, with the latest figure at $69.6 million in Q2 2018.

  • For the quarter ending Q2 2018, Research & Development rose 1.37% year-over-year to $69.6 million; the trailing twelve-month figure through Jun 2018 stood at $571.5 million (up 2.4% YoY), and the FY2025 full-year result was $495.9 million, up 20.85% from the prior year.
  • Research & Development for Q2 2018 stood at $69.6 million, up from $68.6 million in the prior quarter.
  • The five-year high for Research & Development was $375.0 million in Q4 2016, with the low at -$57.5 million in Q1 2015.
  • Historically, Research & Development has averaged $83.0 million across 4 years, with a median of $58.6 million in 2015.
  • The largest YoY upside for Research & Development was 550.27% in 2016 against a maximum downside of 4.2% in 2016.
  • Grifols' Research & Development stood at $57.7 million in 2015, then jumped by 550.27% to $375.0 million in 2016, then slumped by 81.7% to $68.6 million in 2017, then gained by 1.37% to $69.6 million in 2018.
  • The last three Research & Development figures came in at $69.6 million (Q2 2018), $68.6 million (Q2 2017), and $375.0 million (Q4 2016), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -2.28 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 3.51 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 3.53 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 2.47 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 12.59 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 1.72 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.37 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 2.49 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 2.65 Bn
10 Grifols 6.05 Bn 5.09 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2018 69.56 Mn
Jun 30, 2017 68.62 Mn
Dec 31, 2016 374.96 Mn
Sep 30, 2016 58.39 Mn
Jun 30, 2016 56.14 Mn
Dec 31, 2015 57.66 Mn
Sep 30, 2015 60.28 Mn
Jun 30, 2015 58.59 Mn
Mar 31, 2015 -57.53 Mn
Sep 30, 2013 42.12 Mn
Jun 30, 2013 38.08 Mn
Mar 31, 2013 38.70 Mn
Dec 31, 2012 -278.59 Mn
Sep 30, 2012 39.60 Mn
Jun 30, 2012 39.02 Mn
Mar 31, 2012 37.15 Mn
Dec 31, 2011 41.74 Mn
Sep 30, 2011 39.92 Mn
Jun 30, 2011 -26.87 Mn
Mar 31, 2011 -15.71 Mn